Nurix TherapeuticsNRIX 
$19.57-2.05%24h
-2.05%24h
Global rank8017
Market cap$949.22M
Change 7d-4.35%
YTD Performance-
SP500 benchmark
P/E0
P/S12.33
Revenue$76.99M
Earnings-$143.95M
Dividend yield-
EPS for Nurix Therapeutics (NRIX)
Nurix Therapeutics has an EPS of $-3.71. In 2021, the company made an earnings per share (EPS) of $-2.73. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for NRIX
-
Value:-
EPS history for Nurix Therapeutics from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2022 | -$3.71 | 35.90% |
| 2021 | -$2.73 | -1.09% |
| 2020 | -$2.76 | - |
View the highest EPS stocks
